Apontis Pharma AG
ISIN: DE000A3CMGM5 | Ticker: APPH | LEI: 894500ETO1J6MR8PDF91
Country: Germany
APONTIS PHARMA AG is a leading pharmaceutical company in Germany that specialises in single pills. Single Pills combine two to three generic active ingredients in one combination preparation. APONTIS PHARMA develops, markets and distributes a broad portfolio of Single Pills and other medicines, with a particular focus on cardiovascular diseases. Since 2013, APONTIS has successfully launched several Single Pills solely for cardiovascular indications such as hypertension, hyperlipidaemia and secondary prevention. With its headquarters in Monheim am Rhein, APONTIS PHARMA is located in the heart of Europe's strongest pharmaceutical and chemical region. From here, the company maintains a broad network with research-based pharmaceutical companies and a target customer group of around 23,000 doctors in Germany.
Year founded1946
Served areaGermany
Headcount168
HeadquartersAlfred-Nobel-Str. 10, 40789 Monheim – Germany
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 05.05.23 | Reineke, Silke | Close relation | Buy | EUR 36,625.00 |
| 05.05.23 | Milz, Thomas | Board | Buy | EUR 14,360.00 |
DE000A3CMGM5
LEI894500ETO1J6MR8PDF91
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryHauck Aufhäuser Lampe Privatbank AG
Listed Stock ExchangeKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.